Related Experiment Video
Updated: Jun 2, 2026
06:52
The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project
Published on: November 12, 2009
Summary
Generalised anxiety disorder (GAD) affects 4.4% of adults in England, often going unrecognized. Treatment follows a stepped care approach, starting with education and self-help, escalating to CBT or SSRIs if needed.
Area of Science:
- Psychiatry
- Clinical Psychology
- Public Health
Background:
- Generalised anxiety disorder (GAD) affects 4.4% of adults in England, characterized by persistent, unfocused threat and tension.
- It is a chronic condition with a low remission rate, frequently comorbid with other mental health issues.
- GAD is often underdiagnosed in primary care, with only a third of identified cases receiving treatment.
Purpose of the Study:
- To outline the prevalence and characteristics of Generalised Anxiety Disorder (GAD).
- To highlight diagnostic challenges and the under-recognition of GAD in primary care.
- To detail the National Institute for Health and Care Excellence (NICE) recommended stepped care approach for GAD treatment.
Main Methods:
- Review of prevalence data and diagnostic characteristics of GAD.
- Analysis of treatment seeking behaviors and current treatment rates.
- Description of the NICE stepped care model for GAD management.
Main Results:
- GAD has a 4.4% point prevalence in England's adult population.
- A significant proportion of GAD patients are not diagnosed or treated in primary care.
- The NICE guidelines recommend a stepped care approach, starting with self-help and progressing to therapies like CBT or SSRIs.
Conclusions:
- Primary care physicians should be vigilant for GAD symptoms, even when patients do not explicitly report anxiety.
- A stepped care model provides a structured treatment pathway for GAD.
- Referral criteria include inadequate response to high-intensity interventions, severe impairment, or high risk of self-harm.
Related Concept Videos
01:30Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
01:18Anxiety: Overview
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
01:28Social Anxiety Disorder
Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.
01:27Diagnostic and Statistical Manual of Mental Disorders (DSM)
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
01:22Behavior Therapy
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.